05/07/2019

Recent Oncology Related News

10 ways to reduce the burden of prior authorizations

Prior authorizations are time-consuming and frustrating. Find out how you can reduce the burden in your practice. READ MORE

Prior Authorization Obstacles Unnecessarily Delay Patient Access To Cancer Treatments, Physician Survey Finds

(ASTRO) Apr 25, 2019 - Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists. READ PRESS RELEASE

PBM Horror Stories Volume V: Dangerous Health Care Middlemen & Bureaucracies

To continue raising awareness of the patient impact of pharmacy benefit manager (PBM) abuses on patients with cancer COA recently released the fifth volume in its series of papers documenting real-life PBM horror stories from patients and oncology professionals across the country.

The "PBM Horror Stories" series presents real patient stories collected from community oncology practices of PBM middlemen changing prescriptions without authorization, overruling oncologists, causing unconscionable bureaucratic and clerical errors, and leaving patients with lengthy, unexplained delays in receiving needed medications.

COA is a strong advocate against PBM abuses and raising awareness of the vast body of evidence of the incompetence and greed of PBMs. These middlemen have not only failed to reduce drug prices, but have, ironically, caused them to increase thanks to the network of shadowy rebates and discounts they inflict on patients and pharmacies.

• Click here to read PBM Horror Stories Volume V
• Check out the full library of PBM Horror Stories papers here

CBO’s Report On Single-Payer Health Care Holds More Questions Than Answers

(KHN) May 1, 2019 - The Congressional Budget Office report does clearly communicate that shifting to this type of health system would be a complicated process. READ ARTICLE

The Four Pillars of an Ideal Two-sided Risk Value-based Payment Model in Medical Oncology

Value-based payment models (VBPMs), which aim to incentivize the highest quality care at the lowest possible cost, have become increasingly prevalent in oncology in recent years among commercial and publicly-funded payers in the US.[1] Several recent federal policy initiatives implemented by the Centers for Medicare and Medicaid Services (CMS) have explicitly aimed to spur the growth of VBPMs...READ MORE

ACCC Patient Assistance & Reimbursement Guide 

The 2019 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment. This guide contains directions on program enrollment for more than 130 medications, granting insured, underinsured, and uninsured patients access to oncology drugs at little or no cost. The January 2019 update contains: 

READ MORE AND DOWNLOAD CLICK HERE

CHECK OUT OUR LATEST ISSUE....CLICK HERE